https://www.selleckchem.com/products/gdc-0068.html
Platelet activation is an important side effect of dialysis, resulted in a subsequent release of arachidonic acid (AA) from activated platelets. AA is involved in many pathologic conditions, such as inflammation, asthma, cancer, diabetes, hypertension, and the pathogenesis of kidney disease. The aim of this study was to define whether the dialysis type affects the concentration of AA derivatives in patients with chronic kidney disease. 117 patients were qualified to the study group. Based on the type of renal replacement therapy, patie
إعجاب
علق
شارك
